Markedly elevated D-dimer levels in COVID-19 non-survivors highlight a hypercoagulable state consistent with disseminated intravascular coagulation, despite no significant differences in prothrombin time or activated partial thromboplastin time [37,39]. The gene discussed is F2; the disease is COVID-19.